Bixi Life Sciences LLC is a biotechnology company based in Doylestown, PA, specializing in therapeutic drug and biomarker discovery for liver cancer and hepatitis B. Led by President and CEO Dr. Timothy M. Block, the company is supported by a team of experienced professionals and advisors who have successfully converted academic innovations into valuable companies.
With a focus on converting academic innovations into commercial products, Bixi Life Sciences LLC is managed by the renowned Blumberg Institute and PA Biotech Center. Under the leadership of Dr. Block, the company pioneers the use of glycoproteomics for liver cancer biomarker detection and has made significant advancements in the discovery of antiviral drugs and biomarkers of liver cancer.
Generated from the website